Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Pediatr Infect Dis J. 2011 Aug;30(8):e147-54. doi: 10.1097/INF.0b013e3182191a63.
The long-term mortality in children diagnosed with Haemophilus influenzae meningitis is poorly documented.
We performed a nationwide, population-based cohort study including all Danish children diagnosed at the age between 0 and <5 years with H. influenzae meningitis from 1977 through 1996 and who were alive 1 year after diagnosis. Data were retrieved from medical databases in Denmark. For each H. influenzae meningitis patient, 6 age- and gender-matched population controls were indentified. We constructed Kaplan-Meier survival curves and used Cox regression analysis to estimate mortality rate ratios (MRR) and analyze causes of death. The risk of inpatient admission and of requiring hospital outpatient services during follow-up was calculated.
We identified 1242 H. influenzae meningitis patients and 7452 population controls, with a median follow-up time of 21.3 years. The MRR for patients with H. influenzae meningitis was 1.08 (95% confidence interval, 0.57-2.05), adjusted MRR was 0.97 (95% confidence interval, 0.50-1.89). No increased mortality due to infections, respiratory diseases, or cancer was observed. The overall risk of inpatient admission and of requiring hospital outpatient services for the H. influenzae meningitis patients was increased the first 15 years of follow-up, mainly due to the nervous system diseases and ear diseases, thereafter the risk decreased to that of the population controls.
In a developed country, children younger than 5 years surviving the acute phase of H. influenzae meningitis have no increased long-term mortality and only moderately increased morbidity.
患有流感嗜血杆菌脑膜炎的儿童的长期死亡率记录不佳。
我们进行了一项全国性的基于人群的队列研究,该研究纳入了 1977 年至 1996 年间年龄在 0 至<5 岁之间被诊断为流感嗜血杆菌脑膜炎且在诊断后 1 年仍存活的所有丹麦儿童。数据来自丹麦的医学数据库。为每个流感嗜血杆菌脑膜炎患者,我们确定了 6 名年龄和性别匹配的人群对照。我们构建了 Kaplan-Meier 生存曲线,并使用 Cox 回归分析来估计死亡率比 (MRR) 并分析死亡原因。计算了随访期间住院和需要医院门诊服务的风险。
我们确定了 1242 例流感嗜血杆菌脑膜炎患者和 7452 例人群对照,中位随访时间为 21.3 年。流感嗜血杆菌脑膜炎患者的 MRR 为 1.08(95%置信区间,0.57-2.05),调整后的 MRR 为 0.97(95%置信区间,0.50-1.89)。未观察到因感染、呼吸道疾病或癌症导致的死亡率增加。流感嗜血杆菌脑膜炎患者住院和需要医院门诊服务的总体风险在前 15 年的随访中增加,主要是由于神经系统疾病和耳部疾病,此后风险降至人群对照的水平。
在发达国家,5 岁以下儿童在急性流感嗜血杆菌脑膜炎阶段存活后,长期死亡率没有增加,只有中度增加的发病率。